4D Molecular Therapeutics (FDMT) Capital Expenditures (2020 - 2025)
4D Molecular Therapeutics (FDMT) reported Capital Expenditures of -$70,000 for Q4 2025, compared with $949,000 a year earlier.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Capital Expenditures (2020 - 2025) Analysis & Trends
For FY2025, 4D Molecular Therapeutics posted Capital Expenditures of $536,000, down 85.8% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $3.79 million in FY2024 (+36.6%), $2.77 million in FY2023 (-76.0%), $11.54 million in FY2022 (+26.6%) and $9.11 million in FY2021 (+811.0%).
- Five-year quarterly Capital Expenditures spans a low of -$91,000 in Q3 2025 and a high of $6.41 million in Q1 2022.
- Year over year, Capital Expenditures gained in two of the last six quarters, with growth averaging 38.9%.
- The high point for year-over-year Capital Expenditures in five years was Q4 2021 (growth of 903.1%); the low point was Q1 2023 (a decline of 84.2%).
- Per Business Quant data, the three quarters before Q4 2025 came in at -$91,000 (Q3 2025), $66,000 (Q2 2025) and $631,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 949,000.00 |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 349,000.00 |
| Mar 31, 2024 | 710,000.00 |
| Dec 31, 2023 | 549,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 805,000.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 2.07 Mn |
| Mar 31, 2022 | 6.41 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 2.64 Mn |
| Jun 30, 2021 | 737,000.00 |
| Mar 31, 2021 | 642,000.00 |
API Access
4D Molecular Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();